Association between frailty and components of the frailty phenotype with modifiable risk factors and antiretroviral therapy

Journal of Infectious Diseases

Volumn 215, Issue 6, 2017, Pages 933-937

  Erlandson, Kristine M ^a   Wu, Kunling ^b   Koletar, Susan L ^d   Kalayjian, Robert C ^e   Ellis, Ronald J ^f   Taiwo, Babafemi ^g   Palella, Frank J ^g   Tassiopoulos, Katherine ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e METROHEALTH MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antiretroviral therapy; Frail elderly; HIV; Mobility limitation; Muscle strength

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ALCOHOL; ANTIRETROVIRUS AGENT; ATAZANAVIR PLUS RITONAVIR; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGE; ALCOHOL CONSUMPTION; ANTIRETROVIRAL THERAPY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FRAILTY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTECTION; RISK FACTOR; SMOKING; WALKING SPEED; AGED; FRAIL ELDERLY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FRAIL ELDERLY; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS; UNITED STATES; WALKING SPEED; WEIGHT LOSS;

EID: 85019706682     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix063     Document Type: Article

References (14)

1. Smit M, Brinkman K, Geerlings S, et al.; ATHENA observational cohort. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 2015;15:810-8.
2. Erlandson KM, Allshouse AA, Jankowski CM, et al. Risk factors for falls in HIVinfected persons. J Acquir Immune Defic Syndr 2012;61:484-9.
3. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci 2011;66:1030-8.
4. Guaraldi G, Brothers TD, Zona S, et al. A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity. AIDS 2015;29:1633-41.
5. Greene M, Covinsky K, Astemborski J, et al. The relationship of physical performance with HIV disease and mortality. AIDS 2014;28:2711-9.
6. Piggott DA, Muzaale AD, Mehta SH, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One 2013;8:e54910.
7. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA 2011;305:50-8.
8. Kooij KW, Wit FW, Schouten J, et al.; AGEhIV Cohort Study Group. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS 2016;30:241-50.
9. Smurzynski M, Collier AC, Koletar SL, et al. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics. HIV Clin Trials 2008;9:269-82.
10. Newman AB, Gottdiener JS, Mcburnie MA, et al.; Cardiovascular Health Study Research Group. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001;56:M158-66.
11. Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport 2000;71:S114-20.
12. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007;21:1915-21.
13. Herr M, Robine JM, Aegerter P, Arvieu JJ, Ankri J. Contribution of socioeconomic position over life to frailty differences in old age: comparison of life-course models in a French sample of 2350 old people. Ann Epidemiol 2015;25:674-80.e1.
14. Soler-Vila H, García-Esquinas E, León-Muñoz LM, López-García E, Banegas JR, Rodríguez-Artalejo F. Contribution of health behaviours and clinical factors to socioeconomic differences in frailty among older adults. J Epidemiol Community Health 2016;70:354-60.